apomine

DRUG3 trials

Sponsors

Genzyme, a Sanofi Company

Conditions

OsteoporosisUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass

TerminatedNCT00078026

Genzyme, a Sanofi CompanyOsteoporosis

Start: 2003-08-31End: 2004-12-31Target: 60Updated: 2014-02-05

SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid Tumors

CompletedNCT00004049

Genzyme, a Sanofi CompanyUnspecified Adult Solid Tumor, Protocol Specific

Start: 1999-04-30Target: 36Updated: 2018-08-29

SR-45023A in Treating Patients With Advanced Solid Tumors

CompletedNCT00003822

Genzyme, a Sanofi CompanyUnspecified Adult Solid Tumor, Protocol Specific

Start: 1998-08-31Target: 30Updated: 2018-08-29